SYRS - Syros Pharmaceuticals Inc. (SYRS) CEO Nancy Simonian on Q1 2022 Results - Earnings Call Transcript
Syros Pharmaceuticals, Inc. (SYRS) Q1 2022 Earnings Conference Call May 16, 2022, 08:30 AM ET Company Participants Courtney Solberg - Manager, Corporate Communications and IR Nancy Simonian - CEO Jason Haas - CFO David Roth - Chief Medical Officer Kristin Stephens - Chief Development Office Eric Olson - Chief Scientific Officer Conley Chee - Chief Commercial Officer Conference Call Participants Ted Tenthoff - Piper Sandler Eva Previtera - Cowen Jason Butler - JMP Securities Mark Breidenbach - Oppenheimer Zegbeh Jallah - ROTH Capital Partners Matthew Cross - Alliance Global Partners Presentation Operator Good morning and welcome to Syros Pharmaceuticals First Quarter 2022 Financial Results Conference Call. At this time, all participants are in listen-only mode. This call is being webcast live on the Investors & Media section of Syros’ website at www.syros.com. Please be advised that today's conference is being recorded. At this time, I would like to turn the
For further details see:
Syros Pharmaceuticals, Inc. (SYRS) CEO Nancy Simonian on Q1 2022 Results - Earnings Call Transcript